Dowell B L, Falletta J M, Moore J O, Metzgar R S
J Natl Cancer Inst. 1980 Oct;65(4):691-701. doi: 10.1093/jnci/65.4.691.
Two monkey antisera against human thymocytes after absorption with human erythrocytes and peripheral blood leukocytes were shown to detect human thymus-leukemia (HTL)-like antigens. These sera were cytotoxic for thymocytes (> 90% lysis at a 1:10 dilution) but were nonreactive with enriched peripheral blood T- and B-lymphocytes or with cells from myeloid or B-cell lymphoid leukemias. Most (16/17) sheep erythrocyte rosette-forming acute lymphoblastic leukemia (ALL) cells reacted with these sera. Cells from patients with T-cell chronic lymphocytic leukemia, lymphoblastic lymphoma (LBL), and thymoma were also positive. Three of 4 T-cell lymphoblastoid lines derived from ALL patients reacted with these sera. Absorption of the sera with MOLT-4F cells, thymocytes, or LBL cells removed the reactivity against all types of cells tested. However, sera absorbed with the T-cell line HSB remained cytotoxic for thymocytes, MOLT-4F, and most (6/9) T-cell cancers tested. The peripheral blood cell-absorbed sera precipitated a molecule with an apparent molecular weight of 48,000 from lactoperoxidase-labeled thymocytes but not from similarly labeled peripheral blood lymphocytes. The ability of the sera to precipitate this antigen was decreased by absorption with thymocytes, MOLT-4, or LBL cells but not by absorption with HSB, SB, or non-T, non-B ALL cells. Sequential precipitation studies suggested that the HTL antigen was not associated with beta 2 microglobulin.
两种经人红细胞和外周血白细胞吸收后的抗人胸腺细胞猴抗血清,被证明可检测到人胸腺白血病(HTL)样抗原。这些血清对胸腺细胞具有细胞毒性(在1:10稀释时裂解率>90%),但与富集的外周血T淋巴细胞和B淋巴细胞或髓系或B细胞淋巴瘤白血病细胞无反应。大多数(16/17)形成绵羊红细胞玫瑰花结的急性淋巴细胞白血病(ALL)细胞与这些血清发生反应。T细胞慢性淋巴细胞白血病、淋巴母细胞淋巴瘤(LBL)和胸腺瘤患者的细胞也呈阳性。来自ALL患者的4个T细胞淋巴母细胞系中有3个与这些血清发生反应。用MOLT - 4F细胞、胸腺细胞或LBL细胞吸收血清后,可消除对所有测试细胞类型的反应性。然而,用T细胞系HSB吸收的血清对胸腺细胞、MOLT - 4F和大多数(6/9)测试的T细胞癌仍具有细胞毒性。外周血细胞吸收的血清从乳过氧化物酶标记的胸腺细胞中沉淀出一种表观分子量为48,000的分子,但从类似标记的外周血淋巴细胞中未沉淀出。用胸腺细胞、MOLT - 4或LBL细胞吸收后,血清沉淀该抗原的能力降低,但用HSB、SB或非T、非B ALL细胞吸收则不会降低。连续沉淀研究表明,HTL抗原与β2微球蛋白无关。